Literature DB >> 33317760

Role of pharmacist during the COVID-19 pandemic: A scoping review.

Marília Berlofa Visacri1, Isabel Vitória Figueiredo2, Tácio de Mendonça Lima3.   

Abstract

BACKGROUND: Since the start of the new Coronavirus (COVID-19) outbreak in December 2019, pharmacists worldwide are playing a key role adopting innovative strategies to minimize the adverse impact of the pandemic.
OBJECTIVES: To identify and describe core services provided by the pharmacist during the COVID-19 pandemic.
METHODS: A literature search was performed in MEDLINE, Embase, Scopus, and LILACS for studies published between December 1st, 2019 and May 20th, 2020 without language restriction. Studies that reported services provided by pharmacists during the COVID-19 pandemic were included. Two independent authors performed study selection and data extraction with a consensus process. The pharmacist's intervention identified in the included studies were described based on key domains in the DEPICT v.2.
RESULTS: A total of 1189 records were identified, of which 11 studies fully met the eligibility criteria. Most of them were conducted in the United States of America (n = 4) and China (n = 4). The most common type of publication were letters (n = 4) describing the workplace of the pharmacist in hospitals (n = 8). These findings showed the different roles of pharmacists during the COVID-19 pandemic, such as disease prevention and infection control, adequate storage and drug supply, patient care and support for healthcare professionals. Pharmacists' interventions were mostly conducted for healthcare professionals and patients (n = 7), through one-to-one contact (n = 11), telephone (n = 6) or video conference (n = 5). The pharmacists' main responsibility was to provide drug information for healthcare professionals (n = 7) as well as patient counseling (n = 8).
CONCLUSIONS: A reasonable number of studies that described the role of the pharmacists during the COVID-19 pandemic were found. All studies reported actions taken by pharmacists, although without providing a satisfactory description. Thus, future research with more detailed description as well as an evaluation of the impact of pharmacist intervention is needed in order to guide future actions in this and/or other pandemic.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Pharmaceutical services; Pharmacists; Review

Year:  2020        PMID: 33317760     DOI: 10.1016/j.sapharm.2020.07.003

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  39 in total

1.  Extent of and Factors Associated with Self-Medication among Clients Visiting Community Pharmacies in the Era of COVID-19: Does It Relieve the Possible Impact of the Pandemic on the Health-Care System?

Authors:  Aklilu Tekeba; Yohanes Ayele; Belay Negash; Tigist Gashaw
Journal:  Risk Manag Healthc Policy       Date:  2021-12-13

2.  Physicians' and Nurses' Perceptions of Pharmacists' Competencies, and Their Needs of Pharmacists during COVID-19.

Authors:  Kayoko Takeda Mamiya; Kazumasa Hirata
Journal:  Pharmacy (Basel)       Date:  2022-06-13

3.  What has changed in the pharmaceutical care after COVID-19: Pharmacists' perspective.

Authors:  Zelal Kharaba; Sedq A Moutraji; Rama A Al Khawaldeh; Yassen Alfoteih; Ahmad Z Al Meslamani
Journal:  Pharm Pract (Granada)       Date:  2022-06-01

4.  Assessing health-related behaviors among Jordanian children during COVID-19 pandemic: A cross-sectional study.

Authors:  Samar Thiab; Muna Barakat; Raja'a Qudah; Iman Basheti; Safa Daoud
Journal:  Pharm Pract (Granada)       Date:  2022-06-08

5.  Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think?

Authors:  Hadi A Almansour; Nouf M Aloudah; Tariq M Alhawassi; Betty Chaar; Ines Krass; Bandana Saini
Journal:  J Pharm Policy Pract       Date:  2021-05-06

6.  Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic.

Authors:  Maria Marchese; Angela Heintzman; Mark Pasetka; Flay Charbonneau; Carlo DeAngelis; Christine Peragine
Journal:  J Oncol Pharm Pract       Date:  2021-02-07       Impact factor: 1.809

7.  Prevalence of Fibromyalgia in Pharmacy Professionals and Students: A Cross-Sectional Study.

Authors:  Shiekha S AlAujan; Haya M Almalag; Mohammed A Omair
Journal:  J Pain Res       Date:  2021-03-31       Impact factor: 3.133

8.  Pharmacists' experience, competence and perception of telepharmacy technology in response to COVID-19.

Authors:  Suhaib M Muflih; Sayer Al-Azzam; Sawsan Abuhammad; Sara K Jaradat; Reema Karasneh; Mohammad S Shawaqfeh
Journal:  Int J Clin Pract       Date:  2021-04-21       Impact factor: 3.149

9.  COVID-19 infected patients' experiences in Syria, and the role of the pharmacists during their infection.

Authors:  Razan I Nassar; Samar Thiab; Kinda T Alkoudsi; Iman A Basheti
Journal:  Pharm Pract (Granada)       Date:  2022-02-28

Review 10.  COVID the Catalyst for Evolving Professional Role Identity? A Scoping Review of Global Pharmacists' Roles and Services as a Response to the COVID-19 Pandemic.

Authors:  Kaitlyn E Watson; Theresa J Schindel; Marina E Barsoum; Janice Y Kung
Journal:  Pharmacy (Basel)       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.